Accendra Health, Inc. (ACH) is a publicly traded the market company. As of May 21, 2026, ACH trades at $2.68 with a market cap of $209.84M and a P/E ratio of 0.00. ACH moved +0.00% today. Year to date, ACH is +34.85%; over the trailing twelve months it is flat. Its 52-week range spans $1.84 to $4.69. Analyst consensus is neutral with an average price target of $4.44. Rallies surfaces ACH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Accendra Health Shares Surge After Q1 Earnings Beat and Balance Sheet Deal: Accendra Health beat consensus estimates in Q1 2026, driving shares higher. The company simultaneously announced a comprehensive balance sheet optimization transaction to strengthen liquidity and reduce leverage.
| Metric | Value |
|---|---|
| Price | $2.68 |
| Market Cap | $209.84M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.12% |
| 52-Week High | $4.69 |
| 52-Week Low | $1.84 |
| Volume | 22.08K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
4 analysts cover ACH: 0 strong buy, 2 buy, 1 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $4.44.